Safety and Efficacy assessment of Product on ski
- Registration Number
- CTRI/2022/04/042257
- Lead Sponsor
- Sun Pharmaceutical Industries Limited
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1)Indian female subjects
2)Healthy subjects (no infectious and evolutive pathology which could make the subject vulnerable and stop the study, no pathology which could interfere with the study, no symptom in the process of an exploratory checkup)
3)Between 18 and 35 years of age.
4)Skin is healthy on the studied anatomic unit (e.g. free of eczema, wounds, inflammatory scar)
5)Having oily or mixed oily skin type on the face. (Visual assessment by dermatologist)
1)Being pregnant or breastfeeding or having stopped to breastfeed in the past three months
2)Having refused to give her assent by not signing the consent form
3)Taking part in another study liable to interfere with this study
4)In the previous 6 months
-Having started, changed or stopped a hormonal treatment (e.g. hormonal contraception, cyproterone acetate)
-Having taken an oral retinoid-based treatment
-Having undergone a physical (e.g., phototherapy, laser) or chemical (peeling) treatment for acne
5)In the previous 1 month
-Having had a local benzoyl-peroxide-based treatment or a local retinoid-based treatment
-Having had an oral treatment with a base of cimetidine, zinc (zinc gluconate) or spironolactone
6)In the previous 2 weeks
-Having applied cosmetic products with anti-seborrheic aims or cosmetics for oily skin
-Having had oral or local antibiotic treatment for acne
7)In the previous 1 week
-Having had beauty treatment (e.g. skin cleansing, exfoliation, scrub, mask)
-Having a suntanned skin on the studied areas which could interfere with the evaluations of the study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method